Renflexis 100 MG vials
Ended Awarded
- Contract number
- SPE2DB26FX3YM
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $30,659
Award facts
- Contract value 100% obligated
- $30,659.12 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a $30,659.12 delivery order to AmerisourceBergen Drug Corp on October 28, 2025, for the supply of Renflexis 100 mg vials. This firm fixed-price delivery order, which is not set-aside designated, represents a competitively awarded transaction under the company's existing DLA contract vehicle. The work is scheduled for completion by October 29, 2025, with performance taking place at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. Renflexis is a biosimilar medication used to treat various inflammatory conditions, and this award reflects DLA's ongoing procurement of pharmaceutical products to support military and federal healthcare systems.
This delivery order is issued under AmerisourceBergen Drug Corp's substantial Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. This prime contract vehicle enables comprehensive global pharmaceutical support across multiple therapeutic domains, including specialty medications, brand-name and generic drugs, and medical supplies. As a major pharmaceutical distributor, AmerisourceBergen Drug Corp serves as a critical vendor for federal medical procurement, providing essential medicines and healthcare commodities to support military healthcare programs, the Defense Health Agency, and other government healthcare systems worldwide.
Quick answers
Who was awarded contract SPE2DB26FX3YM?
SPE2DB26FX3YM was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on October 28, 2025.
How much is contract SPE2DB26FX3YM worth?
The government has obligated $30,659 on SPE2DB26FX3YM.
Is contract SPE2DB26FX3YM an order under another contract?
Yes. SPE2DB26FX3YM is a delivery order under SPE2DB22D3301, an indefinite delivery contract.
Was contract SPE2DB26FX3YM competed?
The extent of competition for SPE2DB26FX3YM was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award